Lenton, S., Dietze, P., Degenhardt, L., Darke, S. and Butler, T. (2009). Naloxone for administration by peers in cases of heroin overdose. Medical Journal of Australia, 198, (8), pp. 469. doi:10.5694/j.1326-5377.2009.tb02891.x [RJ685] View web page
Lenton, S., Dietze, P., Degenhardt, L., Darke, S. and Butler, T. (2009). Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia. Drug and Alcohol Review, 28, (6), pp. 583-585. doi:10.1111/j.1465-3362.2009.00125.x [RJ702] View web page
Lenton, S. (2008). Commentary: Case for peer naloxone further strengthened. Addiction, 103, (10), pp. 1658-1659. doi:10.1111/j.1360-0443.2008.02346.x [RJ623] View web page
Hargreaves, K., M., Lenton, S., Phillips, M. and Swensen, G. (2002). Potential impacts on the incidence of fatal heroin-related overdose in Western Australia: A time series analysis. Drug and Alcohol Review, 21, (4), pp. 321-327. doi:10.1080/0959523021000023162 [RJ384] View web page
Hargreaves, K., M. and Lenton, S. (2001). The Naloxone Feasibility Study. National Drug Research Institute, Curtin University of Technology, Perth, Western Australia. [T89]
Lenton, S. and Hargreaves, K., M. (2000). Editorial: A trial of naloxone for peer administration has merit, but will the lawyers let it happen? Drug and Alcohol Review, 19, (4), pp. 365-369. [RJ353] View web page
Lenton, S. and Hargreaves, K., M. (2000). Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Medical Journal of Australia, 173, (4), pp. 260-263. [RJ326] View web page